The following information is about BRCA2.

BRCA2 Defined

Are you looking for additional Cancer > Brca2 news? Try our new "Brca2 News Focus" area.

Off-site BRCA2 Links, User Submitted

The following links have been collected through user bookmark submission in the BRCA2 category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Fri Jun 26

• New cancer drug 'shows promise': Olaparib was given to 19 patients with inherited forms of advanced breast, ovarian and prostate cancers caused by mutations of the BRCA1 and BRCA2 genes.

Sat Jun 6

• New breast cancer drug class stars at ASCO - FierceBiotech: In one trial, Sanofi Aventis reported that BSI-201 in combination with chemotherapy extended average survival times by three and a half months, to 9.2 months. That study involved 116 women whose triple-negativ e breast cancer had metastasized. And in a non-randomized study involving 52 women with BRCA1 and BRCA2 mutations, AstraZeneca� 39;s olaparib spurred tumor shrinkage that reached up to 41 percent.

Tue Jun 2

• New Drug May Treat Triple-Negativ e Breast Cancer: An experimental class of drugs may have potential for the treatment of two types of breast cancer that are notoriously difficult to treat.

Fri May 22

• INTELLECTUAL "PROPERTY": How human genes become patented - 20% of all human genes now patented: I've been against this since the 1980s. It's sickening that people will die of breast cancer because they can't afford to pay royalties on a diagnoses method that isn't priced at a free market value because they've patented the testing of certain genes. Our genetics belong to all of us. Life should not be patentable. Yet another failing of intellectual "property " -- the idea that if you have an idea first, or observe a gene first -- that you "own" ; it. What self-serving capitalistic b.s. It holds us all back. People die so that someone else can get rich. Originally from CNN: http://www.cnn .com/2009/HEAL TH/05/13/genes .patent.myriad /

Tue May 19

• Who owns your genes?

Thu May 14

• Cancer Patients Challenge the Patenting of a Gene - NYTimes.com: Salt Lake City, Utah based Myriad genetics is in a lawsuit row against 100,000 odd plaintiffs that may prevent the company from patenting the two critical genes (BRCA1&2) that may increase the risk for breast cancer. The chief contention by the complainers involve around the fact that free market dynamics will lead to better and cheaper screening test for these genes.

Wed May 13

• Cancer Patients Challenge the Patenting of a Gene
• ACLU Challenges Patents On Breast and Ovarian Cancer Genes: NEW YORK ? The American Civil Liberties Union and the Public Patent Foundation at Benjamin N. Cardozo School of Law (PUBPAT) filed a lawsuit today charging that patents on two human genes associated with breast and ovarian cancer stifle research that could lead to cures and limit women's options regarding their medical care. Mutations along the genes, known as BRCA1 and BRCA2, are responsible for most cases of hereditary breast and ovarian cancers. The lawsuit argues that the patents on these genes are unconstitution al and invalid.

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > BRCA2. If you would like to find related tags we recommend Tag Patterns > BRCA2

Off-site Brca2 Research Links

If you still need additional information on Brca2 then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.